Showing results (591-600 of 2,712) with videos related to

Sort By:
Pageof 272
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 9, 2025
Hemocompatibility related complications in Impella 5+ patients treated with Bivalirudin and dual antiplatelet therapy: a SHEAR score evaluationMarta Bandini, Serena Querio, Elena Utzeri, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 2, 2025
Combined mitral and tricuspid TEER with a single TriClip steerable guide catheter: A single-center studyGeorgios E Papadopoulos, Ilias Ninios, Sotirios Evangelou, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 8, 2025
Predictors of permanent pacemaker implantation after TAVI with Navitor transcatheter heart valveMatteo Casenghi, Sara Corradetti, Stefano Rigattieri, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 22, 2025
Mid-term outcomes of balloon-expandable vs. self-expanding valves for valve-in-valve TAVR: Insights from the Michigan Structural Heart ConsortiumAhmad Jabri, Sant Kumar, Amr Abbas, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 10, 2025
Immediate versus delayed coronary angiography in patients with non-ST segment elevation acute coronary syndrome complicated with acute decompensated heart failure: The EARLY-HF randomized clinical trialYongwhan Lim, Seongho Park, Donghyeon Joo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|October 14, 2025
In-hospital outcomes of acute myocardial infarction and in-stent restenosis among end-stage renal disease patients: Insight from National Inpatient SampleIslam Shatla, Islam Y Elgendy, Sudarshan Balla, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 16, 2025
Heparin pretreatment in patients with ST-segment elevation myocardial infarction: A meta-analysisLuca Franchin, Federico Angriman, Andrea Pezzato, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|August 7, 2025
Seven years of follow-up of first-in-human percutaneous epicardial-only left atrial appendage closure using Sierra deviceMichał Piotrowski, Julia Izabela Karpierz, Radosław Litwinowicz, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 30, 2023
Trend, Predictors, and Outcomes of Transcatheter Aortic Valve Implantation in Patients With End-Stage Renal Disease: Insights From the Nationwide Readmissions DatabaseHarigopal Sandhyavenu, Waqas Ullah, Irisha Badu, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|February 3, 2026
Long-term causes of death in patients who underwent mitral transcatheter edge-to-edge repairAntonio Popolo Rubbio, Mihail Celeski, Antonio Sisinni, et al.
Pageof 272